Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IMMUNOMEDICS-INC-9671/news/Immunomedics-Reports-Sacituzumab-Govitecan-IMMU-132-is-Active-in-Patients-With-Metastatic-Small-Ce-24163640/?utm_source=whatsapp&utm_medium=social&utm_campaign=share